We are live on
!
Find out more
BA
Bennicas & Associates Portfolio holdings
AUM
$173M
1-Year Est. Return
1.55%
This Fund
S&P 500
This Quarter
Est. Return
-7.39%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
–
AUM
$145M
AUM Growth
–
Cap. Flow
+$153M
Cap. Flow
% of AUM
106.04%
Top 10 Holdings %
Top 10 Hldgs %
33.97%
Holding
91
New
91
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$15.5M |
| 2 |
Sprott Physical Gold and Silver Trust
CEF
|
+$5.24M |
| 3 |
Merck
MRK
|
+$4.75M |
| 4 |
Chevron
CVX
|
+$4.31M |
| 5 |
GG
Goldcorp Inc
GG
|
+$4.24M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 18.72% |
| 2 | Healthcare | 14.02% |
| 3 | Materials | 13.27% |
| 4 | Energy | 8.56% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASA
26
ASA Gold and Precious Metals
ASA
$904M
| $2.1M | 1.45% |
+165,300
| New | +$2.46M |
|
27
Unilever
UL
$134B
| $2.03M | 1.4% |
+44,596
| New | +$2.12M |
|
28
Rayonier
RYN
$6.56B
| $2.02M | 1.39% |
+53,777
| New | +$2.08M |
|
29
GSK
GSK
$104B
| $1.97M | 1.36% |
+31,520
| New | +$2M |
|
30
Sanofi
SNY
$107B
| $1.93M | 1.34% |
+37,534
| New | +$2M |
|
31
PepsiCo
PEP
$187B
| $1.91M | 1.32% |
+23,367
| New | +$1.91M |
|
32
Bunge Global
BG
$23.1B
| $1.85M | 1.28% |
+26,134
| New | +$1.84M |
|
33
Eli Lilly
LLY
$1.05T
| $1.85M | 1.28% |
+37,660
| New | +$2.05M |
|
34
AbbVie
ABBV
$450B
| $1.76M | 1.21% |
+42,490
| New | +$1.86M |
|
35
Healthpeak Properties
DOC
$15.5B
| $1.7M | 1.17% |
+40,955
| New | +$1.87M |
|
36
RTX Corp
RTX
$261B
| $1.68M | 1.16% |
+28,635
| New | +$1.69M |
|
37
TotalEnergies
TTE
$181B
| $1.67M | 1.15% |
+34,300
| New | +$1.69M |
|
38
Verizon
VZ
$182B
| $1.67M | 1.15% |
+33,111
| New | +$1.69M |
|
|
ARMH
39
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $1.66M | 1.15% |
+45,800
| New | +$1.97M |
|
40
ConocoPhillips
COP
$140B
| $1.57M | 1.09% |
+25,970
| New | +$1.58M |
|
41
Copart
CPRT
$25.6B
| $1.53M | 1.06% |
+398,400
| New | +$1.69M |
|
42
IBM
IBM
$200B
| $1.53M | 1.06% |
+8,369
| New | +$1.63M |
|
43
Abbott
ABT
$175B
| $1.48M | 1.02% |
+42,510
| New | +$1.56M |
|
44
Pfizer
PFE
$143B
| $1.35M | 0.93% |
+50,814
| New | +$1.4M |
|
45
Pan American Silver
PAAS
$17.6B
| $1.28M | 0.89% |
+110,125
| New | +$1.4M |
|
|
CB
46
DELISTED
CHUBB CORPORATION
CB
| $1.27M | 0.88% |
+15,000
| New | +$1.31M |
|
47
DNP Select Income Fund
DNP
$4.17B
| $1.26M | 0.87% |
+127,934
| New | +$1.31M |
|
48
Annaly Capital Management
NLY
$16.9B
| $1.16M | 0.8% |
+22,975
| New | +$1.34M |
|
49
Freeport-McMoran
FCX
$83.9B
| $1.11M | 0.77% |
+40,368
| New | +$1.23M |
|
50
Equinor
EQNR
$88.8B
| $1.09M | 0.75% |
+52,500
| New | +$1.21M |
|
Similar funds
CCM
AWM
S
BFS
SCM
RCC
WWA
NEGWA
Bennicas & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Bennicas & Associates, which disclosed 91 positions worth $145M. Its ten largest holdings account for 34% of the portfolio.
Its largest position is Procter & Gamble: 197,800 shares worth $15.2M.
By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, followed by Healthcare and Materials.
- Bennicas & Associates's largest Q2 2013 buy was Procter & Gamble: 197,800 shares worth $15.2M.
- Bennicas & Associates's ten largest holdings make up 34% of its $145M portfolio in Q2 2013.
- Bennicas & Associates disclosed 91 positions in Q2 2013, its first 13F filing on record.
Based on Bennicas & Associates's 13F filing for Q2 2013, filed 23 Jul 2013.